Follow

Half-year Report

01 April 2021 - 08:00
RNS Number : 2152U
Angelfish Investments PLC
01 April 2021
 

1 April 2021

 

 

Angelfish Investments Plc

 

("Angelfish" or "the Company")

 

Interim Results for the Half-Year to 30 June 2020

 

 

 

The Board of Angelfish Investments Plc (the "Board") today announces the Company's unaudited results for the six months to 30 June 2020 (the "Period").  The Company reports a loss before amortisation of Preference Shares for the Period of £192,619 (2019: £1,446,862 loss) and a loss before taxation for the Period of £471,599 (2019: £1,725,842 loss).

 

Statement by the Board

Following the challenges the Company had faced in 2019, during the Period the Directors took further steps to minimise further cash outgoings whilst discussions took place with a number of interested parties to seek to refinance the Company and secure its future prospects.

 

In March 2020, the Company entered into formal discussions with Brian Jones to commence a refinancing process for the Company. This process took longer than envisaged due to the global pandemic and on 18 June 2020, the Company entered into a framework agreement with Mr Jones under which he provided £30,000 of funding in the form of convertible loan notes and, subject to the conversion of the preference shares then in issue to ordinary shares, was to provide a further £20,000 of funding which would result in  him holding 29.90% of the ordinary shares capital of the company following the conversion of both the loan notes and the preference shares. This was completed on 25 September 2020.

 

Updates on the Company's current investment portfolio are set out below:

Wallet Ads

Development of the platform has been delayed due to the need for additional working capital which Wallet Ads has not yet been successful in raising.

Rapid Nutrition

On receipt of the final repayment of the loans provided to Rapid the Company accepted 232,010 fully paid ordinary shares in Rapid to cover any remaining interest and in recognition of the support provided to Rapid throughout the duration of the loan. These shares were duly received on 21 February 2020, taking the total holding to 482,010 ordinary shares, of which 132,010 have subsequently been sold.

XMG

The balance of the loan to XMG at 31 December 2019 was £178,776 of which £100,000 is secured by way of a personal guarantee provided by the director of XMG. Having reviewed this investment and in light of the developments during 2020 resulting in significant ongoing delays at this stage the Directors have written the investment down to nil whilst still seeking the recovery of this balance.

Just Bee Drinks

The Covid-19 crisis saw a significant impact on sales as key customers streamlined their product lines. After significant Board discussions it was decided that the Company was to close down its drinks production and that they were to be replaced by a new range of vitamin honey products. Since this change in strategic direction, early sales growth has been very encouraging with and Just Bee continues to make steady progress. The Board have reviewed this investment in light of these developments and are of the view that it is fairly reflected at cost in these accounts.


ASSIF

ASSIF is establishing a mental health and wellness platform. It will primarily be a community for peer to peer support for people worried about mental health. Within the platform will be tools to help individuals with their mental health, including gamification and breathing videos. ASSIF is using cutting edge technology to deliver these tools and will have a consumer application and a business to business platform.

The directors of ASSIF are continuing to develop the platform not withstanding the delays many businesses experienced in 2020, during which time the platform was totally redesigned and refocused. As a result the Board are in discussions with ASSIF with options ranging from an early exit to providing further development capital should the Company have funds available for further investment.

 

 

No interim dividend on ordinary shares is to be paid in relation to the Period.  No interim dividend on ordinary shares was paid in relation to the six months to 30 June 2019.

 

 

On behalf of the Board

 

 

 

Brian Jones

Non - executive Chairman

Angelfish Investments Plc

31 March 2021

 

 

 

 

 

INTERIM INCOME STATEMENT (UNAUDITED)

For the period ended 30 June 2020

 

                                                                                                                                    

 

 

Angelfish Investments plc

 

 

6 mths to

 

6 mths to

 

 

30 June

 

30 June

 

 

2020

 

2019

 

 

£ GBP

 

£ GBP

 

 

 

 

 

Revenue

 

0

 

0

Cost of Sales

 

0

 

0

 

 

 

 

 

Gross Profit/(Loss)

 

0

 

0

 

 

 

 

 

Other Operating Income

 

50,984

 

27,500

Administrative Expenses

 

(88,167)

 

 (151,706)

 

 

 

 

 

Loss before Investment Activities

 

(37,183)

 

(124,206)

 

 

 

 

 

Fair Value of Receivables through Profit and Loss

 

0

 

(510,715)

Revaluation of loan

 

0

 

22,727

Provision against Amounts Receivable

 

(18,690)

 

(802,084)

Interest Income

 

26,704

 

130,866

Interest Payable at 7.1% on Preference Shares

 

(163,450)

 

(163,450)

 

 

 

 

 

(Loss) before Amortisation of Preference Shares

 

(192,619)

 

(1,446,862)

 

 

 

 

 

Amortisation of Preference Shares

 

(278,980)

 

(278,980)

 

 

 

 

 

Profit/(Loss) before Taxation

 

(471,599)

 

(1,725,842)

 

 

 

 

 

Taxation Expense

 

0

 

0

 

 

 

 

 

Total Comprehensive Income attributable to Equity Holders of the Company

 

(471,599)

 

(1,725,842)

 

 

 

 

STATEMENTS OF FINANCIAL POSITION (UNAUDITED)

As at 30 June 2020

 

 

 

Angelfish Investments plc

 

As at

 

As at

 

30 June

 

30 June

 

2020

 

2019

 

£ GBP

 

£ GBP

 

 

 

 

Assets

 

 

 

Non-current assets

 

 

 

Property, plant and equipment

685

 

1,446

Investments

154,014

 

553,981

 

154,699

 

555,427

 

 

 

 

Current assets

 

 

 

Trade and other receivables

220,741

 

875,757

Cash and cash equivalents

11,610

 

137,386

 

232,351

 

1,013,143

 

 

 

 

Total assets

387,050

 

1,568,570

 

 

 

 

 

 

 

 

Equity and liabilities

 

 

 

Equity

 

 

 

Issued share capital

71,008

 

71,008

Retained earnings

(4,441,482)

 

(2,339,634)

 

(4,370,474)

 

(2,268,626)

Non current liabilities

 

 

 

Loans and borrowings

4,201,187

 

3,628,228

 

 

 

 

Current liabilities

 

 

 

Trade and other payables

556,337

 

208,968

 

 

 

 

Total liabilities

4,757,524

 

3,837,196

 

 

 

 

 

 

 

 

Total equity and liabilities

387,050

 

1,568,570

 

 

 

NOTES:

 

1. The above financial information was approved by the Board on 31 March 2021.

 

2. The above financial information is unaudited and does not constitute statutory accounts within the meaning of Section 434 of the Companies Act 2006.

 

3. There have not been any changes in accounting policies which affect the validity of the comparison of the financial information presented for the period to 30 June 2020 versus the comparative financial information presented for the period to 30 June 2019.

 

4. The information in this announcement has not been reviewed by the Company's auditor.

 

This announcement contains information which, prior to its disclosure, was inside information as stipulated under Regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310 (as amended).

 

THE DIRECTORS OF THE COMPANY TAKE RESPONSIBILITY FOR THE CONTENTS OF THIS ANNOUNCEMENT

 

 

Enquiries:

 

 

 

 

Angelfish Investments Plc

 

 

Brian Jones

                  +44 (0)7747 113620

 

 

 

 

AQSE Exchange Corporate Adviser

Novum Securities Ltd

David Coffman  

 

+44 (0)207 399 9400 

 

About Angelfish Investments Plc

 

The Company's Ordinary Shares are admitted to trading on the AQSE Exchange Growth Market in London. The Company has the AQSE trading symbol ANGP for its Ordinary Shares.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NEXKFLFXFXLBBBD
Provided by: RNS
AQSE Growth Market (United Kingdom)
Angelfish Investments plc
The Company's investment strategy is focused on businesses and companies in the service and technology sectors, including products related to social or life enhancement. The Directors intend to identify investee businesses and companies where they perceive the opportunity for significant growth through early stage opportunities and/or market opportunities. It is intended that the Company will, pri...
Learn more about company

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More